Page 1 of Clinical Trials for Antirheumatic Agents, 6652 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
Last Updated: August 9, 2011
Condition(s): Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
2
Not yet recruiting
A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy
Last Updated: May 22, 2012
Condition(s): Arthritis, Rheumatoid
3
Completed
A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis
Last Updated: April 20, 2011
Condition(s): Rheumatoid Arthritis
4
Completed
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
Last Updated: February 23, 2012
Condition(s): Rheumatoid Arthritis
5
Completed
A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis
Last Updated: July 31, 2008
Condition(s): Rheumatoid Arthritis
6
Completed
Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
Last Updated: March 16, 2012
Condition(s): Rheumatoid Arthritis
7
Completed
Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs)
Last Updated: February 9, 2012
Condition(s): Rheumatoid Arthritis
8
Completed
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
Last Updated: March 26, 2008
Condition(s): Arthritis; Psoriatic
9
Active, not recruiting
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis
Last Updated: November 19, 2009
Condition(s): Rheumatoid Arthritis
10
Terminated
A Study to Evaluate the Clinical Benefits of Tramadol/Acetaminophen (Ultracet) Versus Diclofenac in the Treatment of Pain in Patients With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)
Last Updated: April 26, 2010
Condition(s): Ankylosing Spondylitis; Pain
11
Active, not recruiting
Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain
Last Updated: March 11, 2012
Condition(s): Seronegative Spondyloarthropathies
12
Completed
INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs
Last Updated: January 20, 2012
Condition(s): Rheumatoid Arthritis
13
Recruiting
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Last Updated: April 18, 2011
Condition(s): Rheumatoid Arthritis
14
Completed
A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications
Last Updated: March 18, 2011
Condition(s): Arthritis, Rheumatoid
15
Active, not recruiting
The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis
Last Updated: October 6, 2011
Condition(s): Inflammatory Arthritis
16
Not yet recruiting
A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy
Last Updated: May 21, 2012
Condition(s): Arthritis, Rheumatoid
17
Completed
A Post Marketing Observational Study (PMOS) of the Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biological Disease Modifying Anti-rheumatic Drugs (BDMARDs) Over 1 Year
Last Updated: September 22, 2011
Condition(s): Moderate to Severe Plaque Psoriasis
18
Not yet recruiting
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
Last Updated: April 18, 2012
Condition(s): Rheumatoid Arthritis
19
Active, not recruiting
Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)
Last Updated: September 21, 2011
Condition(s): Rheumatoid Arthritis
20
Active, not recruiting
Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)
Last Updated: April 27, 2010
Condition(s): Rheumatoid Arthritis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Antirheumatic+Agents

Page 1 of Clinical Trials for Antirheumatic Agents, 6652 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About